To gain further knowledge about the expression of MTSS1 in AML, samples in the publicly available data sets GSE6891 [33] and GSE1159 [34] were grouped into favorable, intermediate, and poor risk groups according to cytogenetic risk [35] and ELN recommendations [36], respectively. Here, MTSS1 is linked to acute myeloid leukemia.